Amarin Corporation PLC
NASDAQ:AMRN

Watchlist Manager
Amarin Corporation PLC Logo
Amarin Corporation PLC
NASDAQ:AMRN
Watchlist
Price: 0.52 USD -8.69% Market Closed
Market Cap: 213.7m USD
Have any thoughts about
Amarin Corporation PLC?
Write Note

Intrinsic Value

AMRN's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one AMRN stock under the Base Case scenario is 1.1 USD. Compared to the current market price of 0.52 USD, Amarin Corporation PLC is Undervalued by 53%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AMRN Intrinsic Value
1.1 USD
Undervaluation 53%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Amarin Corporation PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for AMRN cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about AMRN?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Biotechnology Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Amarin Corporation PLC

Provide an overview of the primary business activities
of Amarin Corporation PLC.

What unique competitive advantages
does Amarin Corporation PLC hold over its rivals?

What risks and challenges
does Amarin Corporation PLC face in the near future?

Has there been any significant insider trading activity
in Amarin Corporation PLC recently?

Summarize the latest earnings call
of Amarin Corporation PLC.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Amarin Corporation PLC.

Provide P/S
for Amarin Corporation PLC.

Provide P/E
for Amarin Corporation PLC.

Provide P/OCF
for Amarin Corporation PLC.

Provide P/FCFE
for Amarin Corporation PLC.

Provide P/B
for Amarin Corporation PLC.

Provide EV/S
for Amarin Corporation PLC.

Provide EV/GP
for Amarin Corporation PLC.

Provide EV/EBITDA
for Amarin Corporation PLC.

Provide EV/EBIT
for Amarin Corporation PLC.

Provide EV/OCF
for Amarin Corporation PLC.

Provide EV/FCFF
for Amarin Corporation PLC.

Provide EV/IC
for Amarin Corporation PLC.

Show me price targets
for Amarin Corporation PLC made by professional analysts.

What are the Revenue projections
for Amarin Corporation PLC?

How accurate were the past Revenue estimates
for Amarin Corporation PLC?

What are the Net Income projections
for Amarin Corporation PLC?

How accurate were the past Net Income estimates
for Amarin Corporation PLC?

What are the EPS projections
for Amarin Corporation PLC?

How accurate were the past EPS estimates
for Amarin Corporation PLC?

What are the EBIT projections
for Amarin Corporation PLC?

How accurate were the past EBIT estimates
for Amarin Corporation PLC?

Compare the revenue forecasts
for Amarin Corporation PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Amarin Corporation PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Amarin Corporation PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Amarin Corporation PLC compared to its peers.

Compare the P/E ratios
of Amarin Corporation PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Amarin Corporation PLC with its peers.

Analyze the financial leverage
of Amarin Corporation PLC compared to its main competitors.

Show all profitability ratios
for Amarin Corporation PLC.

Provide ROE
for Amarin Corporation PLC.

Provide ROA
for Amarin Corporation PLC.

Provide ROIC
for Amarin Corporation PLC.

Provide ROCE
for Amarin Corporation PLC.

Provide Gross Margin
for Amarin Corporation PLC.

Provide Operating Margin
for Amarin Corporation PLC.

Provide Net Margin
for Amarin Corporation PLC.

Provide FCF Margin
for Amarin Corporation PLC.

Show all solvency ratios
for Amarin Corporation PLC.

Provide D/E Ratio
for Amarin Corporation PLC.

Provide D/A Ratio
for Amarin Corporation PLC.

Provide Interest Coverage Ratio
for Amarin Corporation PLC.

Provide Altman Z-Score Ratio
for Amarin Corporation PLC.

Provide Quick Ratio
for Amarin Corporation PLC.

Provide Current Ratio
for Amarin Corporation PLC.

Provide Cash Ratio
for Amarin Corporation PLC.

What is the historical Revenue growth
over the last 5 years for Amarin Corporation PLC?

What is the historical Net Income growth
over the last 5 years for Amarin Corporation PLC?

What is the current Free Cash Flow
of Amarin Corporation PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Amarin Corporation PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Amarin Corporation PLC

Current Assets 650.2m
Cash & Short-Term Investments 305.7m
Receivables 112.6m
Other Current Assets 231.8m
Non-Current Assets 100.4m
PP&E 8m
Intangibles 17.1m
Other Non-Current Assets 75.3m
Current Liabilities 201.6m
Accounts Payable 40.5m
Accrued Liabilities 161m
Non-Current Liabilities 17.7m
Other Non-Current Liabilities 17.7m
Efficiency

Earnings Waterfall
Amarin Corporation PLC

Revenue
241m USD
Cost of Revenue
-104.9m USD
Gross Profit
136.1m USD
Operating Expenses
-180m USD
Operating Income
-43.9m USD
Other Expenses
4.5m USD
Net Income
-39.3m USD

Free Cash Flow Analysis
Amarin Corporation PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

AMRN Profitability Score
Profitability Due Diligence

Amarin Corporation PLC's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

22/100
Profitability
Score

Amarin Corporation PLC's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

AMRN Solvency Score
Solvency Due Diligence

Amarin Corporation PLC's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
57/100
Solvency
Score

Amarin Corporation PLC's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AMRN Price Targets Summary
Amarin Corporation PLC

Wall Street analysts forecast AMRN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AMRN is 1.02 USD with a low forecast of 1.01 USD and a high forecast of 1.05 USD.

Lowest
Price Target
1.01 USD
94% Upside
Average
Price Target
1.02 USD
96% Upside
Highest
Price Target
1.05 USD
102% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for AMRN?

Click here to dive deeper.

Dividends

Amarin Corporation PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for AMRN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

AMRN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

AMRN News

Other Videos

Profile

Amarin Corporation PLC Logo
Amarin Corporation PLC

Country

Ireland

Industry

Biotechnology

Market Cap

213.9m USD

Dividend Yield

0%

Description

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. The firm is focused on the commercialization and development of therapeutics for cardiovascular disease management. The firm operates through the development and commercialization of Vascepa segment. Its lead product, Vascepa (icosapent ethyl) capsule for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The firm sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

Contact

DUBLIN
First Floor, Block 3, The Oval,, Shelbourne Road, Ballsbridge
+35316699020.0
www.amarincorp.com

IPO

1993-04-01

Employees

560

Officers

CEO, President & Director
Mr. Aaron D. Berg
Executive VP, President of Research & Development and Chief Scientific Officer
Dr. Steven B. Ketchum Ph.D.
Executive VP, Chief Legal & Compliance Officer and Secretary
Mr. Jonathan N. Provoost
VP, Global Controller, Principal Financial Officer & Principal Accounting Officer
Mr. Peter Fishman
Senior VP of Corporate Business Development & Investor Relations
Mr. Jordan Zwick
President of Europe & Senior VP
Mr. Laurent Abuaf
Show More
Chief Medical Officer of Global Medical Affairs
Dr. Nabil Abadir
Executive VP of Technical Operations & President of Europe
Dr. David Keenan Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one AMRN stock?

The intrinsic value of one AMRN stock under the Base Case scenario is 1.1 USD.

Is AMRN stock undervalued or overvalued?

Compared to the current market price of 0.52 USD, Amarin Corporation PLC is Undervalued by 53%.

Back to Top